Bayesian Network Modelling for the Clinical Diagnosis of Alzheimer's Disease
Bate St Cliere, A.-R.; Fenton, N.
Show abstract
Alzheimers disease (AD) is a progressively debilitating disease commonly affecting the elderly. Correct diagnosis is important for patients to access suitable therapies and support that can help improve or manage symptoms of the condition. Reports of misdiagnosis and difficulty diagnosing AD highlight existing clinical challenges. Here we propose a Bayesian network as a preliminary model for a complementary clinical diagnostic tool for dementia due to AD and mild cognitive impairment due to AD. The model structure was built based on medical reasoning patterns which help bridge the gap between clinical professionals and algorithmic decision making. The parameters of the model were specified from a combination of learning from data (using the NACC Uniform Data Set), extracting data from literature, and knowledge-based judgment. The resulting model includes variables laid out in NIA-AA diagnostic criteria and differentiates actual AD cases from formal AD diagnoses. The model is validated against a range of real-world data. Unlike machine-learnt (black box) AI models, this model provides a visible and auditable justification for its predictions and can be used for multiple types of what if analysis. An easy-to-use web accessible version of the model has been made available.
Matching journals
The top 1 journal accounts for 50% of the predicted probability mass.
Similar papers in this journal
- c-Triadem: A constrained, explainable deep learning model to identify novel biomarkers in Alzheimer’s disease 96%
- Examining heterogeneity in dementia using data-driven unsupervised clustering of cognitive profiles 94%
- Random forest model for feature-based Alzheimer's disease conversion prediction from early mild cognitive impairment subjects 94%
Similar papers in this journal
- Predicting cognitive decline in a low-dimensional representation of brain morphology 93%
- A FinnGen pilot clinical recall study for Alzheimer’s disease 92%
- Selecting the most important self-assessed features for predicting conversion to Mild Cognitive Impairment with Random Forest and Permutation-based methods 92%
Similar papers in this journal
- Screening for early-stage Alzheimer's disease using optimized feature sets and machine learning 95%
- Examining a Preclinical Alzheimer’s Cognitive Composite for Telehealth Administration, the tPACC, for Reliability between In-Person and Remote Cognitive Testing with Neuroimaging Biomarkers 94%
- Working Towards a Blood-Derived Gene Expression Biomarker Specific for Alzheimer’s Disease 94%
Similar papers in this journal
- A metabolite-based machine learning approach to diagnose Alzheimer's-type dementia in blood: Results from the European Medical Information Framework for Alzheimer's Disease biomarker discovery cohort 94%
- LD-informed deep learning for Alzheimer’s gene loci detection using WGS data 93%
- Brain simulation augments machine-learning-based classification of dementia 92%